生物
卵母细胞
粒体自噬
DNM1L型
生殖医学
线粒体
不育
细胞生物学
SIRT3
线粒体分裂
秀丽隐杆线虫
线粒体生物发生
卵子发生
线粒体DNA
生殖生物学
后生
表观遗传学
自噬
生物信息学
生殖系统
生殖系
卵母细胞激活
生发泡
锡尔图因
遗传学
胚胎
调节器
粒线体疾病
线粒体融合
作者
Cheng-Rung Huang,Yin-Hua Cheng,Yung-Chiao Chang,Pei-Ling Weng,Kuo‐Chung Lan
标识
DOI:10.1093/biolre/ioag035
摘要
Dynamin-related protein 1 (DRP1) is a central regulator of mitochondrial fission and plays a critical role in maintaining mitochondrial function, distribution, and turnover in reproductive cells. Mitochondrial integrity is essential for oocyte quality, folliculogenesis, fertilization, embryonic development, and ultimately, female reproductive longevity. In this review, we synthesize evidence from mammalian and invertebrate models to illustrate the essential roles of DRP1 in reproductive physiology and aging. Genetic deletion or pharmacologic inhibition of DRP1 results in mitochondrial clustering, energy failure, increased reactive oxygen species production, meiotic arrest, and embryo fragmentation. Furthermore, DRP1 dysfunction has been increasingly implicated in age-associated reproductive decline due to impaired mitophagy and defective organelle crosstalk. Model systems such as mice, pigs, and Caenorhabditis elegans have demonstrated that DRP1 activity is modulated by metabolic and epigenetic pathways, including NAD+/sirtuin signaling and GTP metabolism. Therapeutic interventions aimed at restoring DRP1 function-including nicotinamide mononucleotide, coenzyme Q10 (CoQ10), and dietary modulation-have shown promising effects in delaying reproductive aging and improving oocyte or embryo competence in animal models. Despite the current absence of human interventional efficacy data, DRP1 is a plausible and testable target in reproductive biology, with preclinical findings indicating potential relevance to infertility treatment and reproductive aging. This review highlights DRP1 as a key target in reproductive biology, emphasizing its translational potential for treating infertility and mitigating age-related oocyte deterioration.
科研通智能强力驱动
Strongly Powered by AbleSci AI